Following more than two years of negotiation, the In Vitro Diagnostic Directive could be nearing adoption by Member States. Manufacturers will then have a short window of opportunity to obtain the CE mark early in the transition period when it has real competitive value. This article recommends immediate action and looks at some of the issues to consider when choosing a Notified Body.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!